In the AAV-DN DN-Klhl3 administration experiment, DN-KLHL3 was dominantly expressed in the liver and mitigated HF diet-induced obesity with increased energy expenditure, leading to the validation of DN-KLHL3 function in hepatocytes. This evidence concerns the gene KLHL3 and obesity disorder.